CareDx (CDNA) vs Concentra Group Parent (CON)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
CareDx (CDNA) has outperformed Concentra Group Parent (CON) over the past year, gaining 307.5% versus a gain of 106.8%. Concentra Group Parent is the larger company by market cap ($5.26 billion vs $3.68 billion), about 1.4 times the size. On valuation, Concentra Group Parent trades at a lower forward P/E (22.0x vs 44.7x for CareDx).
Concentra Group Parent pays a dividend yielding 0.60%, while CareDx does not currently pay one. Concentra Group Parent converts more of its revenue into profit, with a net margin of 7.7% versus -5.6%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CDNA | CON |
|---|---|---|
| Share price | $70.00 | $41.84 |
| Market cap | $3.68B | $5.26B |
| 1-day change | -2.67% | +0.94% |
| YTD return | +271.55% | +112.60% |
| 1-year return | +307.45% | +106.82% |
| 5-year return | +65.21% | — |
| P/E ratio (TTM) | 29.54 | 24.76 |
| Forward P/E | 44.75 | 21.99 |
| EPS (TTM) | $2.37 | $1.69 |
| Dividend yield | 0.00% | 0.60% |
| Annual dividend | $0.00 | $0.25 |
| Revenue (latest FY) | $379.81M | $2.16B |
| Revenue growth (YoY) | +13.79% | +13.85% |
| Net income (latest FY) | $-21.35M | $166.41M |
| Gross margin | — | 28.34% |
| Operating margin | -8.10% | 15.44% |
| Net margin | -5.62% | 7.69% |
| 52-week high | $90.87 | $44.22 |
| 52-week low | $15.56 | $19.05 |
| Distance from 52-week high | -22.97% | -5.38% |
| Analyst consensus | buy | strong_buy |
| Avg. price target upside | +34.90% | +11.62% |
| Average volume | 1.30M | 1.05M |
| Shares outstanding | 52.54M | 125.72M |
| Employees | 761 | 9,967 |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CDNA has outperformed CON by 200.6 percentage points over the past year.
- Concentra Group Parent is more profitable, keeping 7.7 cents of every revenue dollar as net income versus -5.6 cents for CareDx.
About CareDx
CDNA stock →CareDx, Inc. provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally.
Health Care · Medical Specialities · 761 employees
About Concentra Group Parent
CON stock →Concentra Group Holdings Parent, Inc. provides occupational health services in the United States.
Health Care · Medical Specialities · 9,967 employees
CDNA vs CON FAQ
Which is bigger, CareDx or Concentra Group Parent?
Concentra Group Parent (CON) is larger, with a market capitalization of $5.26B compared with $3.68B for CareDx (CDNA).
Which stock has performed better over the past year, CDNA or CON?
CDNA returned +307.45% over the past 12 months, compared with +106.82% for CON (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, CDNA or CON?
CON has the lower trailing P/E at 24.8, versus 29.5 for CDNA. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, CareDx or Concentra Group Parent?
Concentra Group Parent pays a dividend yielding 0.60%, while CareDx does not currently pay a regular dividend.
Are CareDx and Concentra Group Parent in the same industry?
Yes. Both are classified in the Medical Specialities industry within the Health Care sector.